Article info

PDF

Original article
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

Authors

  1. Correspondence to Professor Robin Spiller, NIHR Nottingham Digestive Diseases Biomedical Research Unit, E Floor West Block, Queen's Medical Centre, University of Nottingham, Derby Road, Nottingham, NG7 2UH, UK; robin.spiller{at}nottingham.ac.uk
View Full Text

Citation

Lam C, Tan W, Leighton M, et al
A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)

Publication history

  • Received 6 January 2015
  • Revised 2 February 2015
  • Accepted 3 February 2015
  • Published in print 1 January 2016.
  • Published online 8 December 2015.
  • Published first 12 March 2015.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.